Teledermatología | #DERMAeSalud AIES & Stiefel GSK
-
Upload
com-salud -
Category
Health & Medicine
-
view
673 -
download
0
Transcript of Teledermatología | #DERMAeSalud AIES & Stiefel GSK
![Page 1: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/1.jpg)
![Page 2: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/2.jpg)
![Page 3: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/3.jpg)
19:30h | TELEDERMATOLOGÍA Situación en diferentes Comunidades Autónomas.
Opciones en consulta pública y privada. Posibilidades y desafíos.
Dr Guillermo Romero Aguilera
Servicio de DermatologíaHospital General Universitario de Ciudad Real
SESCAM
![Page 4: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/4.jpg)
19:30h | TELEDERMATOLOGÍA Situación en diferentes Comunidades Autónomas.
Opciones en consulta pública y privada. Posibilidades y desafíos.
1. Qué es teledermatología: concepto/tipos2. Situación en CCAA3. Opciones privadas4. Posibilidades y desafíos
SESCAM
![Page 5: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/5.jpg)
19:30h | TELEDERMATOLOGÍA Situación en diferentes Comunidades Autónomas.
Opciones en consulta pública y privada. Posibilidades y desafíos.
1. Qué es teledermatología: concepto/tipos2. Situación en CCAA3. Opciones privadas4. Posibilidades y desafíos
SESCAM
![Page 6: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/6.jpg)
![Page 7: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/7.jpg)
Teledermatology practice…………………
![Page 8: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/8.jpg)
![Page 9: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/9.jpg)
![Page 10: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/10.jpg)
OBJETIVO / PROPÓSITO : DX-MANEJO O SEGUIMIENTO
SOLO TD
TDFTF
FTFTD
![Page 11: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/11.jpg)
1. PRIMARIA………PACIENTE TD DERMATÓLOGO
2. SECUNDARIA….PACIENTE MAP TD DERMATÓLOGO
3. TERCIARIA …….PACIENTE DERMATÓLOGO TD DERMATÓLOGO
MODELOS INTERACCIÓN EN TD
1
2
3
![Page 12: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/12.jpg)
19:30h | TELEDERMATOLOGÍA Situación en diferentes Comunidades Autónomas.
Opciones en consulta pública y privada. Posibilidades y desafíos.
1. Qué es teledermatología: concepto/tipos
2. Situación en CCAA3. Opciones privadas4. Posibilidades y desafíos
SESCAM
![Page 13: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/13.jpg)
Current Status of Teledermatology in Spain
Dr Guillermo Romero , Dr Diego de Argila*
Departments of DermatologyHospital General Universitario de C. Real and Hospital
Universitario La Princesa* de Madrid
SESCAM
![Page 14: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/14.jpg)
Introduction
• It’s no clear if teledermatology can be considered a mature application 1.
• In fact it has been doubted his successful implantation in some countries with a long tradition in TD 2.
• However, there are no longitudinal studies evaluating its global development in a particular country.
1 Eminovic N et al Maturity of teledermatology evaluation research: a systematic literature review. Br J D 20072 English JS, Eedy DJ. Has teledermatology in the U.K. finally failed? Br J D 2007
![Page 15: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/15.jpg)
Aims
• Current status of TD in Spain– Organization– Population & Pathology– Adventages & Disadventages
• Development of Spanish TD in last 5 years
Objective: To analyze the degree of implementation of TD in Spain and the most important qualitative and quantitative characteristics of functioning services. Theses include : organization, attended population, tecnology, teaching and researching, advantages and disadventages.We present the results of a comparative longitudinal study of two surveys conducted in 2009 and 2014 by the AEDV Image Group.
![Page 16: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/16.jpg)
Methods• Survey:
– Dr. Romero & Dr. de Argila. (Imaging group AEDV)– Presentation letter– National distribution Abbvie
• Description current results 2014• Comparation with 2009 survey
The proposed access was different in the two surveys. In the first survey, in 2009, we have using a multi-pronged approach, we sought to identify dermatologists practicing teledermatology in Spain. We contacted the members of AEDV Image Group to identify practicing teledermatologists in Spain. In addition, we submitted a request via e-mail to dermatology department heads of the major hospitals in the country. We also demanded to the existing teledermatologists to identify other practicing teledermatologists who might not have been captured with the above outreach efforts.The approach in the second survey was holistic, integral, because using the Abbvit commercial net we could have contact with all dermatology services in the country (267 services)
![Page 17: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/17.jpg)
Index• Organization aspects• Technical aspects• Teaching and researching• Adventages & disadventages.
![Page 18: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/18.jpg)
Methods• Survey:
– Dr. Romero & Dr. de Argila. (Imaging group AEDV)– Presentation letter– National distribution Abbvie
• Description current results 2014• Comparation with 2009 surveyThe proposed access was different in the two surveys. In the first survey, in 2009, we have using a multi-pronged approach, we sought to identify dermatologists practicing teledermatology in Spain. We contacted the members of AEDV Image Group to identify practicing teledermatologists in Spain. In addition, we submitted a request via e-mail to dermatology department heads of the major hospitals in the country. We also demanded to the existing teledermatologists to identify other practicing teledermatologists who might not have been captured with the above outreach efforts.The approach in the second survey was holistic, integral, because using the Abbvit commercial net we could have contact with all dermatology services in the country (267 services)
![Page 19: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/19.jpg)
All 267 centers in Spain were accessed in may 2014• 70 make TD (26%) • 45 filled a wide survey • 25 do not fill wide survey
64% agree to complete a wide survey …………and 36% don’t agree
![Page 20: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/20.jpg)
Spanish centers with TD by autonomies 2009 vs 2014: 21 in 2009 / 70 in 2014
4/8
2/1
2/5
3/72/4
1/15
1/0
1/14
1/6
1/5 1/11/1
Increase >x3
Decrease in 2
Stable in 2
Increase in 9
Null in 5
1/2
0/1
![Page 21: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/21.jpg)
Time service and survival over timeTime with TD
(years) Centers0-4 245-9 12>10 5
5 With >10 yearsSantiago 17
Don Benito 15Badajoz 12C-Real 10Sevilla 10
17/21 activePersist 14/17, 3 more Closed
2009
N= 41RANGE 0.3 TO 17 MEDIAN 4.93
> 10 5-9 < 40
5
10
15
20
25
30
5
12
24
Years with TD
![Page 22: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/22.jpg)
CUESTIONES TÉCNICASOrganization aspects
![Page 23: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/23.jpg)
Tele-dermatologists / Hospital
N = 3632%
37%
16%
5% 11%
Tele-Dermatologists
1234> 5
2009
1843%
1433%
1024%
Dermatologist in Center
1-45-89-15
617%
1542%
617%
38%
617%
Number of Teledermatologists
1234>5
![Page 24: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/24.jpg)
Hours / Week
N = 43
1256%
629%
210%
15%
0,5 a 22 a 55 a 10>10
2009
1639%
1332%
820%
410%
0,5 a 22 a 55 a 10>10
![Page 25: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/25.jpg)
Time to do TD
838%
1048%
314%
Specific time No specific time Other
2009
2252%
1331%
717%
With appointment list and specific time for TDNo specific time “in breaks”Other
![Page 26: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/26.jpg)
Support with other labors in Hospital
N = 42
921%
3379%
Support Staff (nurses or other)
SINO
![Page 27: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/27.jpg)
Data and Pictures
1466%
210%
524%
DOCTOR NURSE MIXED
2009
3479%
512%
49%
Who introduce the patient data?
MEDICAL DOCTORNURSEOTHER
3370%
817%
613%
Who take the pictures?
MEDICAL DOCTORNURSEOTHER
![Page 28: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/28.jpg)
GP Centers
29% All kind, Near and far centers, but only a %- From 10 to 80%- Media 45%
N=42
14%, only 6/42, restricted to farest centers
2252%
1229%
614%
25%
Whole areaAll kind but only a % Only FarestSpecific types
52% Whole area, without
restrictions
![Page 29: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/29.jpg)
How far are the centers?
314%
1047%
629%
210%
<30km 30-100km 100-1000km >1000km
2009
1746%
1643%
411%
Farest distance
<50 km50-100km>100 km
2475%
516%
39%
Nearest distance
<25km25-50km>50km
N = 37
![Page 30: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/30.jpg)
CUESTIONES TÉCNICASTechnical aspects
![Page 31: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/31.jpg)
What kind of Tele-consultation?
1467%
524%
210%Chart Title200935
83%
512%
25%
SF - TD REAL TIME
HYBRID
2014
![Page 32: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/32.jpg)
Tertiary TD
My Department makes consultations to other departments with TD
Other dermatologists make consultations to my Department with TD
615%
3585%
YES, USUALLYSOMETIMESNEVER
12%
512%
3686%
YES, USUALLYSOMETIMESNEVER
N = 42
![Page 33: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/33.jpg)
Pictures / Images
DIGITAL CAMERA BRIDGE
DIGITAL CAMARA HQ
DERMATOSCOPE MOBILE PHONE ECOGRAPH0
5
10
15
20
25
30
35
CAPTURE DISPOSITIVES (GP)
Series1
N = 41 (13 multiple)
![Page 34: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/34.jpg)
Who design the TD system?Public system: Dermatologist & Informatics
HOSPITAL WORKERS (DERMA-TOLOGIST& INFORMATICS); 23IT COMPANY ADAPTED ; 12
IT COMPANY; 6
- IXEMAD - SULIME - BULL - TELEFÓNICA- CENTRICITY- MED VIZER- GENERAL ELECTRICS
Companies / Health Departments
- SERGAS- DERCAM- OSAKIDETZA
N = 41
Mixed: Software specifically adapted
Commercial Software
![Page 35: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/35.jpg)
DATA COLLECTION DESIGN: TAKING PART DERMATOLOGIST
1362%
838%
SiNo
2009
2460%
1640%
YESNO
![Page 36: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/36.jpg)
What kind of software?
14%
28%58%
Is it possible to explode the data?
NOSINS/NC
29%
27%
44% Free space to replyPredederminated and mandatory itemsmixed
What kind of software?26%
14%60%
Is it available a diagnosis codifi-cation?
NOYESNS/NC
N = 41
![Page 37: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/37.jpg)
TD system is linked with electronic clinical history?
419%
1781%
Si No
200928; 64%
14; 32%
2; 5%
YESNONA
N = 44
![Page 38: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/38.jpg)
Satisfaction with TD system(by dermatologists)
12%
717%
3481%
NS/NC0-55-10
MEAN 7.15
![Page 39: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/39.jpg)
What kind of population and pathologies?
![Page 40: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/40.jpg)
SPECIFIC CONDITIONS FOR TDPopulation targeted.
942%
943%
210%
15%
General Disperse Remote Prisons
2009
42%
31%
8%
8% 12%
General populationGeographic dispersionRemote PopulationPrisonsNursing Homes
![Page 41: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/41.jpg)
Distribution of diseases
1257%
838%
15%
General Oncology Esthetic
2009
3461%
1425%
35%
59%
General DermatologyOncologyProffesional dermatosisOther
![Page 42: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/42.jpg)
Direct Appointment in Surgery Room
1740%
2660%
YESNO
N = 43
![Page 43: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/43.jpg)
Teaching & Researching
![Page 44: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/44.jpg)
Research & Publications
1640%
2460%
Research results
YESNO
616%
3184%
Publications
YESNO
![Page 45: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/45.jpg)
Tele-training to GPs
838%
733%
629%
No yes Seminars Teleconsultation
20092009
717%
717%
1331%
12%
1433%
WITH TELECONSULTATIONSEMINARS AND MEETINGSBOTHOTHERSNONE
N = 42
![Page 46: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/46.jpg)
Patient Satisfaction Surveys
419%
1781%
YesNo
2009
820%
3380%
YESNO
![Page 47: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/47.jpg)
Main problems to implement TD systems
210%
837%
419%
210%
524%
HIS Primary Care Gerency Other None
2009
613%
37%
1840%
37%
716%
49%
49%
MEDICAL GERENCYAPPOINTMENT SERVICE (HIS)PRIMARY CAREPATIENTSDERMATOLOGY DE-PARTMENTTECHNOLOGYOTHERS
N = 36 (8multiple)
![Page 48: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/48.jpg)
Satisfaction with TD(Score 0-10)
Average (2014): 6,9
Average (2009): 6,3
![Page 49: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/49.jpg)
Adventages & Disadventages
![Page 50: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/50.jpg)
Adventages (dermatologist point of view) Score 0 10
Main advantages of using the system TD (qualify of 0-10, with 0 being strongly disagree, 10 Total agreement)
IMPROVE C
OMMUNICATION W
ITH GP
SCREE
NING OF C
OMMON DISEASES
PRIORIZATIO
N IN ONCOLO
GY
PRIORIZATIO
N OF EMER
GENCIES
SAVING VISI
TS AND PATIE
NTS TR
AVELS
IMPROVE G
P TRAINING
IMPROVE G
LOBAL P
ATIENT M
ANAGEMEN
T0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
7.66 7.648.29
7.857.60
6.906.60
![Page 51: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/51.jpg)
DISADVENTAGES (dermatologist point of view)Main disadvantages or problems using the TD system qualify of 0-10, with 0 being the
problem does not exist at all, 10 very serious and difficult problem to solve):
DIFFICULT
COORDINATION W
ITH P
RIMARY C
ARE
LACK O
F DER
MATOLO
GISTS C
OOPERATIO
N
LACK O
F GPs C
OOPERATIO
N
PICTURES
WITH BAS Q
UALITY
RISK OF M
EDICAL M
ISTAKE
TIME C
ONSUMING
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
3.73
2.64
3.95
6.38
5.75
3.37
![Page 52: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/52.jpg)
Summary of results I:Centers and organization.
• All Spain centers 267 were surveyed, 70 had TD (26.2%) • Increase 21 to 70, x3 in 5 years (2009 2014)• Progressive increase Time service: 59% <4a, 29% 5-9 a, 5 >10
años; Range 0.3-17 years, median 4.93y• In 5 years 14/17 active centers survive from 2009, <20% have
been closed.• In each serviceTD is a subunity, from 2009 there are an increase of
active dermatologists and TD hours by week.• Only 20% with nurse participing, specific time for performance
increase from 38 to 52% in SC,
![Page 53: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/53.jpg)
Summary of results IITechnology
• SFTD is the predominant technique and this primacy continuous to increase (from 67 to 83%).
• 15% make Tele DSC, 13% use smart-phone, and 15% practice tertiary TD.
• Software only 20% commercial no adapted, 60% design with Dermatologist collaboration. Linked with e-HIS in 64% (only 19% in 2009);Codification <33%;
• Satisfaction with technology system 7.15 (mean) and only 20% <5 (score 0-10)
![Page 54: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/54.jpg)
• Attention to disperse/remote fall 53% in 2009 to 39% in 2014; • Primary Care: only farest 15%, all type of centers 85%.
• More center are in Urban setting, 50% don’t assist any patient >50km.
• Pathology: all type 60%, oncology 25%
• GP-Learning in 66%
Summary of results IIIObjectives
![Page 55: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/55.jpg)
Global satisfaction 6.3 in 2009 increase to 6.9 in 2014 (score 0-10)
>
Summary of results IVAdvantages & Disadvantages
![Page 56: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/56.jpg)
19:30h | TELEDERMATOLOGÍA Situación en diferentes Comunidades Autónomas.
Opciones en consulta pública y privada. Posibilidades y desafíos.
1. Qué es teledermatología: concepto/tipos2. Situación en CCAA
3. Opciones privadas4. Posibilidades y desafíos
SESCAM
![Page 57: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/57.jpg)
TD PRIVADA
![Page 58: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/58.jpg)
TD PRIVADA
![Page 59: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/59.jpg)
TD PRIVADA
![Page 60: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/60.jpg)
TD PRIVADA
![Page 61: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/61.jpg)
TD PRIVADA
![Page 62: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/62.jpg)
TD PRIVADA
• Consentimiento.
• privacidad //https// cifrado// claves //
• Quien remite paciente?.
• Hay seguimiento?.
• Seguro médico / responsabilidad.
• Control de riesgos: calidad fotos y seguridad en dx.
![Page 63: Teledermatología | #DERMAeSalud AIES & Stiefel GSK](https://reader035.fdocuments.ec/reader035/viewer/2022062823/5879b4a11a28ab6b2c8b658b/html5/thumbnails/63.jpg)
19:30h | TELEDERMATOLOGÍA Situación en diferentes Comunidades Autónomas.
Opciones en consulta pública y privada. Posibilidades y desafíos.
1. Qué es teledermatología: concepto/tipos2. Situación en CCAA3. Opciones privadas
4. Posibilidades y desafíos PREGUNTAS
SESCAM